Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Mutual

ETCHX Holdings: What Eventide Healthcare & Life Sciences Fund Owns

Ticker ETCHX · · Holdings as of Jun 30, 2026

Expense ratio
2.29%$229/yr per $10k
5-yr return
−0.1%annualized
1-yr return
+55.1%as of Dec 2025
Net assets
$1.8Ball share classes
Holdings
93

Bottom line

What does ETCHX hold?

ETCHX held 93 positions as of Jun 30, 2026. Its largest holding is Guardant Health Inc at 5.37% of the fund, and the top 10 positions add up to 32.4%. By asset type it is 0% do, 94% stocks, 1% preferred stock.

Updated Aug 31, 2026

ETCHX top 25 holdings

#HoldingType% of fundValue
1 Guardant Health Inc
GUARDANT HEALTH
Stocks 5.37%$96.1M
2 US Bank Mmda
US BANK MMDA - USBGFS 9
Cash & short-term funds 3.75%$67.0M
3 Mirum Pharmaceuticals Inc
MIRUM PHARMACEUT
Stocks 3.47%$62.1M
4 Kymera Therapeutics Inc
KYMERA THERAPEUT
Stocks 3.22%$57.7M
5 Abivax Sa
ABIVAX SA-ADR
Stocks 2.94%$52.6M
6 BeLite Bio Inc
BELITE BIO INC
Stocks 2.83%$50.6M
7 Trevi Therapeutics Inc
TREVI THERAPEUTI
Stocks 2.77%$49.6M
8 Mbx Biosciences Inc
MBX BIOSCIENCES
Stocks 2.70%$48.2M
9 Vaxcyte Inc Stocks 2.69%$48.1M
10 Cytokinetics Inc Stocks 2.69%$48.0M
11 Argenx Se
ARGENX SE - ADR
Stocks 2.55%$45.6M
12 Ionis Pharmaceuticals Inc
IONIS PHARMACEUT
Stocks 2.55%$45.6M
13 Insmed Inc Stocks 2.40%$43.0M
14 Revolution Medicines Inc
REVOLUTION MEDIC
Stocks 2.36%$42.2M
15 Avalyn Pharma Inc Stocks 2.35%$42.0M
16 Immix Biopharma Inc
IMMIX BIOPHARMA
Stocks 2.24%$40.1M
17 Celldex Therapeutics Inc
CELLDEX THERAPEU
Stocks 2.16%$38.6M
18 Palvella Therapeutics Inc
PALVELLA THERAPE
Stocks 1.98%$35.4M
19 Kestra Medical Technologies Ltd
KESTRA MEDICAL T
Stocks 1.95%$34.8M
20 Scholar Rock Holding Corp
SCHOLAR ROCK HOL
Stocks 1.95%$34.8M
21 Apogee Therapeutics Inc
APOGEE THERAPEUT
Stocks 1.93%$34.5M
22 Definium Therapeutics Inc
DEFINIUM THERAPE
Stocks 1.87%$33.4M
23 Irhythm Holdings Inc
IRHYTHM HOLDINGS
Stocks 1.85%$33.0M
24 Bridgebio Pharma Inc
BRIDGEBIO PHARMA
Stocks 1.82%$32.6M
25 Beta Bionics Inc Stocks 1.80%$32.2M

Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 31, 2026

Asset mix

DO0.2%
Stocks94.2%
Preferred stock1.4%
Cash & short-term funds5.2%

Country exposure

BM2.0%
CA2.4%
FR2.9%
KY1.0%
NL2.6%
US90.2%